[The new insulins: a result of molecular biology prowess, maybe a clinical advance?].
Assan
R
R
Service de Diabétologie, Hôpital Bichat, Paris.
D001682:Biological Availability; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008967:Molecular Biology / Q000379:methods / Q000639:trends*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*
D007328:Insulin; D011994:Recombinant Proteins
Les nouvelles insulines: une prouesse de la biologie moléculaire, peut-être un progrès clinique?